|
Name: Dimethylthiambutene
Type: Opioid
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Dimethylthiambutene, a synthetic opioid, was first synthesized in the 1950s. It was developed for its analgesic properties and was used in pain management. The compound's introduction reflects early research into synthetic opioids. However, its use has been limited due to safety concerns and regulatory controls.
|
|
V. Legal Information
Dimethylthiambutene, a synthetic opioid, is classified as a Schedule I controlled substance in the US, making it illegal. Many countries have similarly banned it due to its high potential for abuse and lack of accepted medical use. The UNODC monitors synthetic opioids, emphasizing the need for strict controls to prevent misuse and address the opioid crisis.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Dimethylthiambutene, a barbiturate derivative, acts as a sedative, leading to drowsiness, decreased heart rate, and muscle relaxation. Short-term effects include effective sedation, while long-term use may result in tolerance, dependence, and respiratory issues. Risks of overdose include severe sedation, respiratory depression, and possible death. Safe use requires medical supervision. Recent research focuses on its sedative efficacy and the risks associated with barbiturate use.  |
|
VII. Psychological Effects
Dimethylthiambutene, a stimulant, affects mood and cognition. Immediate effects include increased energy and cognitive stimulation. Long-term use may result in dependence, mood swings, and cognitive impairments. Recent studies emphasize its stimulant properties and psychological risks, including dependence and mood disorders.
 |
|
VIII. Culture
Dimethylthiambutene, an opioid analgesic, was developed in the mid-20th century but never gained widespread use. The history of opioids spans ancient medicinal use to modern pharmaceutical applications, with ongoing issues related to addiction and regulation. Dimethylthiambutene's cultural significance lies in its place within the broader narrative of opioid development, illustrating the complexities of balancing effective pain management with the risks of abuse and dependence. While not widely recognized in public discourse, it represents the ongoing challenges in opioid pharmacology and the pursuit of safer analgesic options. Media coverage typically focuses on more prominent opioids but highlights the broader context of opioid use and regulation.
 |